Page last updated: 2024-09-03

gefitinib and ku 55933

gefitinib has been researched along with ku 55933 in 2 studies

Compound Research Comparison

Studies
(gefitinib)
Trials
(gefitinib)
Recent Studies (post-2010)
(gefitinib)
Studies
(ku 55933)
Trials
(ku 55933)
Recent Studies (post-2010) (ku 55933)
5,2315662,9191640127

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)ku 55933 (IC50)
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformHomo sapiens (human)0.458
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoformHomo sapiens (human)0.133
Serine/threonine-protein kinase mTORHomo sapiens (human)7.44
DNA-dependent protein kinase catalytic subunitHomo sapiens (human)1.4943
Serine-protein kinase ATMHomo sapiens (human)0.191

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Knight, ZA; Shokat, KM1
Kinomura, A; Misumi, K; Miyata, Y; Okada, M; Sun, J; Tashiro, S1

Reviews

1 review(s) available for gefitinib and ku 55933

ArticleYear
Features of selective kinase inhibitors.
    Chemistry & biology, 2005, Volume: 12, Issue:6

    Topics: Animals; Drug Evaluation, Preclinical; Humans; Phosphoric Monoester Hydrolases; Protein Kinase Inhibitors; Substrate Specificity

2005

Other Studies

1 other study(ies) available for gefitinib and ku 55933

ArticleYear
Enhanced gefitinib-induced repression of the epidermal growth factor receptor pathway by ataxia telangiectasia-mutated kinase inhibition in non-small-cell lung cancer cells.
    Cancer science, 2016, Volume: 107, Issue:4

    Topics: Apoptosis; Ataxia Telangiectasia Mutated Proteins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Morpholines; Mutation; Protein Kinase Inhibitors; Pyrones; Quinazolines; Signal Transduction

2016